| Symbol |
Name |
|
AIM2
|
absent in melanoma 2
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
APOBEC3H
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
BCAP31
|
B-cell receptor-associated protein 31
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRD4
|
bromodomain containing 4
|
|
CADM1
|
cell adhesion molecule 1
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASZ1
|
castor zinc finger 1
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCHCR1
|
coiled-coil alpha-helical rod protein 1
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD207
|
CD207 molecule, langerin
|
|
CDC25A
|
cell division cycle 25A
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHD6
|
chromodomain helicase DNA binding protein 6
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSTF2T
|
cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant
|
|
CTSB
|
cathepsin B
|
|
CTSL
|
cathepsin L
|
|
CUX1
|
cut-like homeobox 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DDX11
|
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11
|
|
DEK
|
DEK proto-oncogene
|
|
DFFB
|
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
|
|
DYNLT1
|
dynein, light chain, Tctex-type 1
|
|
DYNLT3
|
dynein, light chain, Tctex-type 3
|
|
E2F1
|
E2F transcription factor 1
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXO5
|
F-box protein 5
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FHIT
|
fragile histidine triad
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXP3
|
forkhead box P3
|
|
GATA3
|
GATA binding protein 3
|
|
GIPC1
|
GIPC PDZ domain containing family, member 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNLR1
|
interferon, lambda receptor 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IL32
|
interleukin 32
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INSR
|
insulin receptor
|
|
IPO5
|
importin 5
|
|
IRF1
|
interferon regulatory factor 1
|
|
ITGA6
|
integrin, alpha 6
|
|
JAM3
|
junctional adhesion molecule 3
|
|
JUN
|
jun proto-oncogene
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNIP3
|
Kv channel interacting protein 3, calsenilin
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KIAA0226L
|
KIAA0226-like
|
|
KPNA1
|
karyopherin alpha 1 (importin alpha 5)
|
|
KPNA4
|
karyopherin alpha 4 (importin alpha 3)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT14
|
keratin 14, type I
|
|
LCN2
|
lipocalin 2
|
|
LIPC
|
lipase, hepatic
|
|
MAGI1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1
|
|
MAGI3
|
membrane associated guanylate kinase, WW and PDZ domain containing 3
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MAML1
|
mastermind-like 1 (Drosophila)
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEST
|
mesoderm specific transcript
|
|
MIR124-2
|
microRNA 124-2
|
|
MIR145
|
microRNA 145
|
|
MIR203A
|
microRNA 203a
|
|
MIR34A
|
microRNA 34a
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NFX1
|
nuclear transcription factor, X-box binding 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOTCH1
|
notch 1
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRIP1
|
nuclear receptor interacting protein 1
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
|
PDCD1
|
programmed cell death 1
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLK1
|
polo-like kinase 1
|
|
PML
|
promyelocytic leukemia
|
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
RAB7B
|
RAB7B, member RAS oncogene family
|
|
RAB9A
|
RAB9A, member RAS oncogene family
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100P
|
S100 calcium binding protein P
|
|
SALL2
|
spalt-like transcription factor 2
|
|
SDC1
|
syndecan 1
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SIPA1L1
|
signal-induced proliferation-associated 1 like 1
|
|
SIRT1
|
sirtuin 1
|
|
SIX1
|
SIX homeobox 1
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNX17
|
sorting nexin 17
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SP1
|
Sp1 transcription factor
|
|
SP100
|
SP100 nuclear antigen
|
|
SPRR3
|
small proline-rich protein 3
|
|
SRPK1
|
SRSF protein kinase 1
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SRSF9
|
serine/arginine-rich splicing factor 9
|
|
TADA3
|
transcriptional adaptor 3
|
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa
|
|
TBX2
|
T-box 2
|
|
TBX3
|
T-box 3
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNPO1
|
transportin 1
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TSG101
|
tumor susceptibility 101
|
|
TXN
|
thioredoxin
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UBR4
|
ubiquitin protein ligase E3 component n-recognin 4
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
USP1
|
ubiquitin specific peptidase 1
|
|
USP12
|
ubiquitin specific peptidase 12
|
|
WDR48
|
WD repeat domain 48
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
